Han B - Search Results

1

Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial.

Cheng Y, Han B, Li K, Wang Q, Zhang L, Shi J, Wang Z, He J, Shi Y, Chen W, Wang X, Luo Y, Nan K, Jin F, Li B, Zhu J. Cheng Y, et al. Among authors: han b. Cancer Med. 2020 Apr;9(8):2621-2630. doi: 10.1002/cam4.2913. Epub 2020 Feb 16. Cancer Med. 2020. PMID: 32064794 Free PMC article. Clinical Trial.

2

[Vascular endothelial growth factor inhibits dendritic cells from patients with non-small cell lung carcinoma].

Fan XH, Han BH, Dong QG, Sha HF, Bao GL, Liao ML. Fan XH, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2003 Sep;26(9):539-43. Zhonghua Jie He He Hu Xi Za Zhi. 2003. PMID: 14521757 Chinese.

3

[Implication of micrometastatic cancer cells in the peripheral blood on prognosis of non-small cell lung cancer].

Huang JS, Dong QG, Bao GL, Han BH. Huang JS, et al. Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):294-6. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312367 Chinese.

4

[Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].

Gu AQ, Han BH, Zhang XY, Shen J, Qi DJ, Xiong LW, Xin Y, Song YY. Gu AQ, et al. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):298-301. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615288 Clinical Trial. Chinese.

5

[Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer].

Gu AQ, Wang HM, Shi CL, Xiong LW, Gao ZQ, Han BH. Gu AQ, et al. Zhonghua Zhong Liu Za Zhi. 2010 Jan;32(1):71-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20211075 Clinical Trial. Chinese.

6

[Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer].

Gao ZQ, Han BH, Sha HF, Shi ZY, Yang XH, Feng JX. Gao ZQ, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2010 Apr;33(4):284-8. Zhonghua Jie He He Hu Xi Za Zhi. 2010. PMID: 20646461 Chinese.

7

[Analysis of Subclassification by Size and Survival-associated Factors of Stage I Non-small Cell Lung Cancer.].

Ji H, Bai H, Han B. Ji H, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2009 Sep 20;12(9):989-94. doi: 10.3779/j.issn.1009-3419.2009.09.009. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719197 Free article. Chinese.

8

[Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer.].

Chu T, Lin H, Shen J, Zhong R, Han B. Chu T, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2009 Nov 20;12(11):1178-83. doi: 10.3779/j.issn.1009-3419.2009.11.10. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723367 Free article. Chinese.

9

[The Analysis of Erlotinib on Brain Metastases in Patients with Non-small-cell Lung Cancer.].

Bai H, Han B. Bai H, et al. Among authors: han b. Zhongguo Fei Ai Za Zhi. 2009 Dec 20;12(12):1271-5. doi: 10.3779/j.issn.1009-3419.2009.12.09. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20723382 Free article. Chinese.

10

Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients.

Han B, Gao G, Wu W, Gao Z, Zhao X, Li L, Qiao R, Chen H, Wei Q, Wu J, Lu D. Han B, et al. Lung Cancer. 2011 May;72(2):238-43. doi: 10.1016/j.lungcan.2010.09.001. Epub 2010 Oct 12. Lung Cancer. 2011. PMID: 20943283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,980 results

Search Page

Filters